Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The British Neuroscience Association is delighted to congratulate Irene Tracey as the new President-Elect for the Federation of European Neuroscience Societies

Professor Irene Tracey is Warden of Merton College, Oxford, one of the University of Oxford's oldest undergraduate and graduate colleges dating back to 1264; she is also Professor of Anaesthetic Neuroscience and Pro-Vice Chancellor (without portfolio). Irene was a founding member and then Director for ten years of the Oxford Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB) followed by heading the Nuffield Department of Clinical Neurosciences. Her work focuses on the neuroscience of pain, specifically pain perception, analgesia and anaesthesia using neuroimaging. Irene was also a trustee of the BNA for many years.

Read more

Similar stories

Highly Cited Researchers 2021

Our researchers feature strongly in the latest list

Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize

In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.

New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.

Experimental Medicine and Industry Partnership

The recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.